[1]Patent:US2003/225094,2003,A1.Locationinpatent:Page13
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
1185293-71-3
1007517-99-8
62821-91-4
647824-46-2
69980-77-4
1177355-20-2
63525-12-2 | 2,4-Dichloro-5-methylbenzaldehyde | AA00IB5I | MFCD11845977
64464-07-9 | 2-(2-Methoxyphenoxy)ethylamine HCl, hydrate | AA00IBAG | MFCD09037366
660416-38-6 | Methyl 3-fluoro-5-methylbenzoate | AA00IBH4 | MFCD06204167
677743-83-8 | 2-Propanamine, 1-methoxy-, hydrochloride | AA00IBOD | MFCD22126049
69242-40-6 | Glycylglycyl-l-isoleucine | AA00IBU8 | MFCD00047934
70692-45-4 | 1-Methyl-2-nitro-4-(trifluoromethoxy)benzene | AA00IC0L | MFCD09954767
722466-18-4 | 2-(2-Cyclohex-1-enyl-ethylamino)-benzoic acid | AA00IC61 | MFCD03956563
7320-34-5 | Diphosphoric acid, tetrapotassium salt | AA00ICAN | MFCD00799110
743453-27-2 | 5-(thiophen-2-yl)-7-(trifluoromethyl)-[1,3]thiazolo[4,5-b]pyridin-2-amine | AA00ICFP | MFCD05263794
757192-83-9 | 1-[1-(3-bromophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]-2-chloroethan-1-one | AA00ICL5 | MFCD06340101